Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Effects of a self-managed home-based walking intervention on psychosocial health outcomes for breast cancer patients receiving chemotherapy: a randomised controlled trial.

Gokal K, Wallis D, Ahmed S, Boiangiu I, Kancherla K, Munir F.

Support Care Cancer. 2016 Mar;24(3):1139-66. doi: 10.1007/s00520-015-2884-5. Epub 2015 Aug 15.

PMID:
26275768
2.

Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial.

Earl HM, Hiller L, Dunn JA, Blenkinsop C, Grybowicz L, Vallier AL, Abraham J, Thomas J, Provenzano E, Hughes-Davies L, Gounaris I, McAdam K, Chan S, Ahmad R, Hickish T, Houston S, Rea D, Bartlett J, Caldas C, Cameron DA, Hayward L; ARTemis Investigators.

Lancet Oncol. 2015 Jun;16(6):656-66. doi: 10.1016/S1470-2045(15)70137-3. Epub 2015 May 11.

3.
4.

Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.

Swain SM, Baselga J, Kim SB, Ro J, Semiglazov V, Campone M, Ciruelos E, Ferrero JM, Schneeweiss A, Heeson S, Clark E, Ross G, Benyunes MC, Cortés J; CLEOPATRA Study Group.

N Engl J Med. 2015 Feb 19;372(8):724-34. doi: 10.1056/NEJMoa1413513.

5.

Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial.

Kunkler IH, Williams LJ, Jack WJ, Cameron DA, Dixon JM; PRIME II investigators.

Lancet Oncol. 2015 Mar;16(3):266-73. doi: 10.1016/S1470-2045(14)71221-5. Epub 2015 Jan 28. Erratum in: Lancet Oncol. 2015 Mar;16(3):e105.

PMID:
25637340
6.

Correlations between morphological appearance and psychosocial difficulties in patients with extensive burns who received allotransplant.

Calotă DR, Niţescu C, Marinescu S, Cristescu C, Boiangiu I, Florescu IP, Lascăr I.

Rom J Morphol Embryol. 2012;53(3 Suppl):703-11.

7.

Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Baselga J, Cortés J, Kim SB, Im SA, Hegg R, Im YH, Roman L, Pedrini JL, Pienkowski T, Knott A, Clark E, Benyunes MC, Ross G, Swain SM; CLEOPATRA Study Group.

N Engl J Med. 2012 Jan 12;366(2):109-19. doi: 10.1056/NEJMoa1113216. Epub 2011 Dec 7.

8.

Concomitant (without adjuvant) temozolomide and radiation to treat glioblastoma: a retrospective study.

Sridhar T, Gore A, Boiangiu I, Machin D, Symonds RP.

Clin Oncol (R Coll Radiol). 2009 Feb;21(1):19-22. doi: 10.1016/j.clon.2008.08.008. Epub 2008 Oct 5.

PMID:
18838255
9.

Sigmoid colon is an unexpected organ at risk in brachytherapy for cervix cancer.

Al-Booz H, Boiangiu I, Appleby H, French C, Coomber H, Humphery P, Cornes P.

J Egypt Natl Canc Inst. 2006 Jun;18(2):156-60.

10.

The role of epoetin beta in the treatment of anaemia in patients with gynaecological malignancies.

Cornes P, Boiangiu I.

Anticancer Res. 2007 Jan-Feb;27(1B):513-22. Review.

11.

Long-term outcomes and morbidity after I125 brachytherapy for localised prostate cancer: an early UK series.

Hellawell GO, Ho K, Halliwell M, Appleby H, Le Monnier K, Boiangiu I, Davies DR, Fellows G, Whipp E, Brewster SF.

Clin Oncol (R Coll Radiol). 2005 Feb;17(1):68-9. No abstract available.

PMID:
15714935

Supplemental Content

Loading ...
Support Center